• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PIPELINE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Occlusion (1984); Vascular Dissection (3160)
Event Date 06/25/2015
Event Type  Injury  
Event Description
Medtronic (covidien) received information from literature review that the following serious adverse events occurred intraprocedural, periprocedural, and during long-term follow up.Intraprocedurally, there were 2 cases of intraluminal thrombus and 1 case of parent vessel occlusion requiring intra-arterial, administration of eptifibatide (180 mg/kg) and deployment of a second ped.There were 4 intraprocedural complication cases in which strokes occurred as a result of acute distal occlusion, secondary to thrombus and branch occlusion.These events occurred in patients under conscious sedation (cs).In 4 patients, cs was converted to general anesthesia (ga) during the procedure after an acute decline in level of consciousness.Periprocedural complications included 4 cerebrovascular accidents (owing to a branch or perforator occlusion), 2 cranial nerve palsies (a third and a sixth nerve palsy in 2 patients with large thrombosed cavernous ica aneurysms), and 1 case of iatrogenic cervical ica dissection that required carotid stent placement.On longer-term follow-up, there were 5 cases of in-stent stenosis requiring angioplasty.The mean duration of follow-up was 6.0 months (range, 3-14.7 months).In this paper, the authors reported the feasibility, safety, and outcomes associated with the use of the ped for intracranial aneurysms performed in awake patients after the administration of conscious sedation (cs) and local anesthetic.Between march 2012 and september 2014, 130 patients with 139 intracranial aneurysm (8 ruptured) were treated with the ped under cs at the authors' institution.During the study period, 130 patients (mean age, 56.16 years; range, 19-82 years; 57 men and 73 women) with 139 aneurysms were successfully treated.Eight of these aneurysms were ruptured and treated in the acute phase.Patients with subarachnoid hemorrhage had a hunt and hess score ranging from i to iii.A total of 155 peds were used in the 139 aneurysms.The mean number of ped deployed for each aneurysm was 1.28 (range, 1-5).During the same procedure, adjunctive coiling was used for the treatment of 23 aneurysms.The main reason for the coils was to obtain prompt aneurysm thrombosis and occlusion.Citation: rangel-castilla l, cress m, munich s, et al.Feasibility, safety, and periprocedural complications of pipeline embolization for intracranial aneurysm treatment under conscious sedation.Operative neurosurgery 0:1-5, 2015.Doi: 10.1227/neu.0000000000000864.
 
Manufacturer Narrative
Article website: http://journals.Lww.Com/neurosurgery/abstract/publishahead/feasibility,_safety,_and_periprocedural.97675.Aspx.The lot history record review was not possible since the lot numbers were not reported.The devices will not be returned for analysis, therefore, the event cause could not be determined.There is limited information about the device and/or the patient, therefore all serious adverse events were captured in this report.Reference 2029214-2015-00814 for intraprocedural device problem events from the same article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key4943223
MDR Text Key6257341
Report Number2029214-2015-00815
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 07/13/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/27/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPIPELINE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/13/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention; Disability;
Patient Age56 YR
-
-